naphazoline has been researched along with Allergic Conjunctivitis in 8 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the current study was to investigate whether olopatadine and naphazoline hydrochloride reduce allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF." | 7.83 | Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF. ( He, H; Quan, L, 2016) |
| "The aim of the current study was to investigate whether olopatadine and naphazoline hydrochloride reduce allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF." | 3.83 | Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF. ( He, H; Quan, L, 2016) |
| "Levocabastine is a newly synthesized histamine H1 antagonist which has been formulated as both eye drops and nasal spray." | 3.77 | New trends in the treatment of allergic conjunctivitis. ( Blockhuys, S; Janssens, M; Parys, W, 1992) |
| "The signs and symptoms of allergic conjunctivitis include ocular redness and itching." | 2.71 | A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model. ( Greiner, JV; Udell, IJ, 2005) |
| "The allergen challenge model of acute allergic conjunctivitis was selected to assess the agent as it provided a standardized and precise way to measure drug effectiveness for this indication." | 2.67 | Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis. ( Abelson, MB; Burns, R; George, MA; Maguire, L; Paradis, A; Smith, LM, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lievens, C | 1 |
| Pucker, AD | 1 |
| McGwin, G | 1 |
| Logan, A | 1 |
| Franklin, Q | 1 |
| Brafford, R | 1 |
| Hogan, C | 1 |
| Kelley, LR | 1 |
| Christensen, M | 1 |
| Quan, L | 1 |
| He, H | 1 |
| KNUPFFER, N | 1 |
| Greiner, JV | 1 |
| Udell, IJ | 1 |
| Dockhorn, RJ | 1 |
| Duckett, TG | 1 |
| Williams, TL | 1 |
| Williams, AJ | 1 |
| Enzenauer, RW | 1 |
| Parys, W | 1 |
| Blockhuys, S | 1 |
| Janssens, M | 1 |
| Abelson, MB | 1 |
| Paradis, A | 1 |
| George, MA | 1 |
| Smith, LM | 1 |
| Maguire, L | 1 |
| Burns, R | 1 |
1 review available for naphazoline and Allergic Conjunctivitis
| Article | Year |
|---|---|
New trends in the treatment of allergic conjunctivitis.
Topics: Animals; Antazoline; Conjunctivitis, Allergic; Cromolyn Sodium; Histamine H1 Antagonists; Humans; Na | 1992 |
4 trials available for naphazoline and Allergic Conjunctivitis
| Article | Year |
|---|---|
A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
Topics: Administration, Topical; Adult; Aged; Allergens; Anti-Allergic Agents; Conjunctivitis, Allergic; Dib | 2005 |
Comparison of Naphcon-A and its components (naphazoline and pheniramine) in a provocative model of allergic conjunctivitis.
Topics: Adult; Allergens; Conjunctivitis, Allergic; Double-Blind Method; Drug Therapy, Combination; Female; | 1994 |
New trends in the treatment of allergic conjunctivitis.
Topics: Animals; Antazoline; Conjunctivitis, Allergic; Cromolyn Sodium; Histamine H1 Antagonists; Humans; Na | 1992 |
Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis.
Topics: Allergens; Antazoline; Conjunctiva; Conjunctivitis, Allergic; Drug Combinations; Drug Therapy, Combi | 1990 |
4 other studies available for naphazoline and Allergic Conjunctivitis
| Article | Year |
|---|---|
Understanding ocular comfort differences between 0.7% olopatadine and 0.3% pheniramine maleate/0.025% naphazoline hydrochloride eye drops.
Topics: Adolescent; Adult; Conjunctivitis, Allergic; Dibenzoxepins; Double-Blind Method; Humans; Naphazoline | 2023 |
Treatment with olopatadine and naphazoline hydrochloride reduces allergic conjunctivitis in mice through alterations in inflammation, NGF and VEGF.
Topics: Animals; Blotting, Western; Conjunctivitis, Allergic; Cytokines; Disease Models, Animal; Drug Therap | 2016 |
[Results of privine and antistin-privine therapy of allergic conjunctivitis].
Topics: Anaphylaxis; Conjunctivitis; Conjunctivitis, Allergic; Humans; Hypersensitivity; Imidazoles; Immune | 1950 |
Case report: unilateral mydriasis from topical Opcon-A and soft contact lens.
Topics: Adult; Conjunctivitis, Allergic; Contact Lenses, Hydrophilic; Drug Combinations; Histamine H1 Antago | 1997 |